T1	PROC 46 88	Estudio unicéntrico, aleatorizado, abierto
T2	PROC 112 141	tratamiento anti-hipertensivo
T3	DISO 1348 1360	intolerancia
#1	AnnotatorNotes T3	C0277585; Intolerance to drug; Pathologic Function
T4	DISO 154 166	hipertensión
#2	AnnotatorNotes T4	C0020538; Hypertensive disease; Disease or Syndrome
T5	DISO 178 186	obesidad
#3	AnnotatorNotes T5	C0028754; Obesity; Disease or Syndrome
T6	DISO 210 222	Hipertensión
#4	AnnotatorNotes T6	C0020538; Hypertensive disease; Disease or Syndrome
T7	DISO 237 245	obesidad
#5	AnnotatorNotes T7	C0028754; Obesity; Disease or Syndrome
T8	DISO 328 336	Obesidad
#6	AnnotatorNotes T8	C0028754; Obesity; Disease or Syndrome
T9	DISO 354 357	HTA
#7	AnnotatorNotes T9	C0020538; Hypertensive disease; Disease or Syndrome
T10	DISO 393 420	afectación severa de órgano
T11	PROC 431 442	Tratamiento
#8	AnnotatorNotes T11	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T12	CHEM 451 472	fármacos hipotensores
T13	CHEM 499 509	creatinina
#9	AnnotatorNotes T13	C0010294; creatinine; Biologically Active Substance · Organic Chemical
T14	ANAT 510 516	sérica
#10	AnnotatorNotes T14	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T15	PROC 562 590	filtrado glomerular estimado
#11	AnnotatorNotes T15	C3811844; Estimated Glomerular Filtration Rate; Laboratory Procedure
T16	PROC 647 665	cirugía bariátrica
#12	AnnotatorNotes T16	C1456587; Bariatric Surgery; Therapeutic or Preventive Procedure
T17	PROC 713 739	consentimiento por escrito
#13	AnnotatorNotes T17	C0811746; Obtain written consent; Health Care Activity
T18	PROC 798 811	exploraciones
#14	AnnotatorNotes T18	C1280903; Exploration procedure; Therapeutic or Preventive Procedure
T19	PROC 952 972	método contraceptivo
T20	DISO 1076 1090	HTA secundaria
#15	AnnotatorNotes T20	C0155616; Secondary hypertension; Disease or Syndrome
T21	DISO 1108 1111	HTA
#16	AnnotatorNotes T21	C0020538; Hypertensive disease; Disease or Syndrome
T22	DISO 1114 1130	lesión de órgano
T23	DISO 1145 1148	IRC
#17	AnnotatorNotes T23	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T24	DISO 1151 1172	cardiopatía isquémica
#18	AnnotatorNotes T24	C0151744; Myocardial Ischemia; Disease or Syndrome
T25	PROC 1187 1211	retirada del tratamiento
#19	AnnotatorNotes T25	C0850893; stop medication; Therapeutic or Preventive Procedure
T26	PROC 1250 1258	operados
#20	AnnotatorNotes T26	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T27	PROC 1262 1280	cirugía bariátrica
#21	AnnotatorNotes T27	C1456587; Bariatric Surgery; Therapeutic or Preventive Procedure
T28	CHEM 1364 1374	olmesartán
#22	AnnotatorNotes T28	C1098320; olmesartan; Organic Chemical · Pharmacologic Substance
T29	CHEM 1376 1386	amlodipino
#23	AnnotatorNotes T29	C0051696; amlodipine; Organic Chemical · Pharmacologic Substance
T30	CHEM 124 141	anti-hipertensivo
T31	CHEM 1389 1393	HCTZ
#24	AnnotatorNotes T31	C0020261; Hydrochlorothiazide; Organic Chemical · Pharmacologic Substance
T32	ANAT 414 420	órgano
#25	AnnotatorNotes T32	C0178784; Organ; Body Part, Organ, or Organ Component | C1280836; Entire body organ; Body Part, Organ, or Organ Component
T33	PROC 592 596	MDRD
#26	AnnotatorNotes T33	C1980036; Creatinine-based formula (MDRD); Laboratory Procedure
T34	ANAT 485 490	renal
#27	AnnotatorNotes T34	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T35	PROC 499 516	creatinina sérica
#28	AnnotatorNotes T35	C0201976; Creatinine measurement, serum (procedure); Laboratory Procedure
T36	PROC 788 795	pruebas
#29	AnnotatorNotes T36	C1510438; Assay; Laboratory Procedure
T37	ANAT 1124 1130	órgano
#30	AnnotatorNotes T37	C0178784; Organ; Body Part, Organ, or Organ Component | C1280836; Entire body organ; Body Part, Organ, or Organ Component
T38	CHEM 1212 1222	hipotensor
#31	AnnotatorNotes T38	C0003364; Antihypertensive Agents; Pharmacologic Substance
T39	Date 13 17	2016
T40	Age 280 323	superior a 18 años e inferior a los 65 años
T42	Neg_cue 381 392	ausencia de
T44	LIVB 529 536	mujeres
#32	AnnotatorNotes T44	C0043210; Woman; Population Group
T45	LIVB 549 556	varones
#33	AnnotatorNotes T45	C0025266; Male population group; Population Group
T48	LIVB 860 905	Mujeres embarazadas o en periodo de lactancia
#34	AnnotatorNotes T48	C0033011; Pregnant Women; Population Group | C4316174; Patients who are breastfeeding; Patient or Disabled Group
T49	LIVB 910 932	Mujeres en edad fértil
#35	AnnotatorNotes T49	C4324275; Woman of childbearing potential; Population Group
T50	Age 921 932	edad fértil
T51	PHYS 896 905	lactancia
#36	AnnotatorNotes T51	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T52	Neg_cue 937 939	no
T53	LIVB 1094 1103	Pacientes
#37	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group
T54	Neg_cue 1177 1183	impida
T56	LIVB 1228 1237	Pacientes
#38	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T57	LIVB 1284 1293	Pacientes
#39	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T41	PHYS 477 490	Función renal
#40	AnnotatorNotes T41	C0232804; Renal function; Organ or Tissue Function
T43	PHYS 868 879	embarazadas
#41	AnnotatorNotes T43	C0032961; Pregnancy; Organism Function
T46	PHYS 562 581	filtrado glomerular
#42	AnnotatorNotes T46	C0232809; Glomerular filtration; Organ or Tissue Function; Laboratory Procedure
T47	ANAT 571 581	glomerular
#43	AnnotatorNotes T47	C0022663; Kidney Glomerulus; Body Part, Organ, or Organ Component | C1284485; Entire glomerulus; Body Part, Organ, or Organ Component
A1	Assertion T10 Negated
A2	Assertion T19 Negated
A3	Population_data T49 Age
A4	Assertion T25 Negated
A5	Status T26 History_of
A6	Status T27 History_of
A7	Status T3 History_of
A8	Assertion T28 Contraindicated
A9	Assertion T29 Contraindicated
A10	Assertion T31 Contraindicated
#44	AnnotatorNotes T30	C0003364; Antihypertensive Agents; Pharmacologic Substance
#45	AnnotatorNotes T2	C0585941; Antihypertensive therapy; Therapeutic or Preventive Procedure 
#46	AnnotatorNotes T12	C0003364; Antihypertensive Agents; Pharmacologic Substance
#47	AnnotatorNotes T19	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T55	Quantifier_or_Qualifier 973 992	de alta efectividad
A11	Assertion T55 Negated
R1	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T55	
R2	Negation Arg1:T52 Arg2:T19	
R3	Negation Arg1:T52 Arg2:T55	
A12	Assertion T38 Negated
R4	Used_for Arg1:T38 Arg2:T25	
R5	Negation Arg1:T54 Arg2:T25	
R6	Negation Arg1:T54 Arg2:T38	
R7	Used_for Arg1:T30 Arg2:T2	
R8	Overlap Arg1:T4 Arg2:T5	
R9	Overlap Arg1:T6 Arg2:T7	
T58	Quantifier_or_Qualifier 337 349	grado II-III
R10	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T58	
T59	Quantifier_or_Qualifier 361 375	grado moderado
#48	AnnotatorNotes T59	C0205081; Moderate (severity modifier); Qualitative Concept
R11	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T59	
R12	Negation Arg1:T42 Arg2:T10	
R13	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T10	
T60	Quantifier_or_Qualifier 421 426	diana
#49	AnnotatorNotes T60	C1521840; Target; Functional Concept
R14	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T60	
T61	Quantifier_or_Qualifier 447 450	< 3
R15	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T61	
R16	Used_for Arg1:T12 Arg2:T11	
R17	Location_of Arg1:T34 Arg2:T41	
R18	Location_of Arg1:T14 Arg2:T35	
T62	Result_or_Value 517 525	< 1,2 mg
R19	Has_Result_or_Value Arg1:T35 Arg2:T62	
R20	Experiences Arg1:T44 Arg2:T35	
R21	Experiences Arg1:T45 Arg2:T35	
T63	Result_or_Value 517 518;539 545	< 1,4 mg
R22	Has_Result_or_Value Arg1:T35 Arg2:T63	
R23	Experiences Arg1:T44 Arg2:T41	
R24	Experiences Arg1:T44 Arg2:T46	
R25	Experiences Arg1:T44 Arg2:T15	
R26	Experiences Arg1:T44 Arg2:T33	
T64	Result_or_Value 598 612	> 60 ml/minuto
R27	Has_Result_or_Value Arg1:T33 Arg2:T64	
R28	Has_Result_or_Value Arg1:T15 Arg2:T64	
R29	Location_of Arg1:T47 Arg2:T15	
R30	Location_of Arg1:T47 Arg2:T46	
R31	Experiences Arg1:T45 Arg2:T46	
R32	Experiences Arg1:T45 Arg2:T15	
R33	Experiences Arg1:T45 Arg2:T33	
T65	Observation 477 497	Función renal normal
#50	AnnotatorNotes T65	C0232805; Normal renal function; Finding
R34	Location_of Arg1:T34 Arg2:T65	
T66	Quantifier_or_Qualifier 630 643	primer tiempo
R40	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T66	
T67	Observation 675 699	adecuadamente informados
#51	AnnotatorNotes T67	C0587903; Patient information status; Finding (?)
R41	Before Arg1:T67 Arg2:T17	
R42	Before Arg1:T17 Arg2:T36	
R43	Before Arg1:T17 Arg2:T18	
T68	Observation 745 769	participar en el estudio
#52	AnnotatorNotes T68	C0587903; Patient information status; Finding (?)
R44	Before Arg1:T17 Arg2:T68	
R45	Experiences Arg1:T48 Arg2:T51	
R46	Experiences Arg1:T48 Arg2:T43	
R47	Has_Age Arg1:T49 Arg2:T50	
R48	Experiences Arg1:T49 Arg2:T19	
R49	Experiences Arg1:T53 Arg2:T21	
R50	Location_of Arg1:T37 Arg2:T22	
T69	Quantifier_or_Qualifier 1131 1136	diana
#53	AnnotatorNotes T69	C1521840; Target; Functional Concept
R51	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T69	
T70	Quantifier_or_Qualifier 1137 1143	severa
#54	AnnotatorNotes T70	C1547227; Severe - Severity of Illness Code; Intellectual Product
R52	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T70	
R53	Experiences Arg1:T53 Arg2:T22	
R54	Experiences Arg1:T53 Arg2:T23	
R55	Experiences Arg1:T53 Arg2:T24	
R59	Overlap Arg1:T21 Arg2:T22	
R60	Overlap Arg1:T21 Arg2:T23	
R61	Overlap Arg1:T21 Arg2:T24	
R62	Experiences Arg1:T53 Arg2:T25	
R63	Experiences Arg1:T56 Arg2:T26	
R64	Experiences Arg1:T56 Arg2:T27	
R65	Experiences Arg1:T57 Arg2:T3	
R66	Causes Arg1:T28 Arg2:T3	
R67	Causes Arg1:T29 Arg2:T3	
R68	Causes Arg1:T31 Arg2:T3	
R69	Overlap Arg1:T9 Arg2:T10	
R35	Experiences Arg1:T44 Arg2:T65	
R36	Experiences Arg1:T45 Arg2:T65	
R37	Experiences Arg1:T45 Arg2:T41	
A13	Status T16 Future
A14	Experiencer T57 Patient
A15	Experiencer T56 Patient
A16	Experiencer T53 Patient
A17	Experiencer T44 Patient
A18	Experiencer T45 Patient
A19	Experiencer T48 Patient
A20	Experiencer T49 Patient
